Screener
Theravance Biopharma TBPH Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
Based on the most recent quarter.
The source filing: Theravance Biopharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 9:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056760
FAQ
- What is Theravance Biopharma's book value per share?
- Theravance Biopharma (TBPH) reported book value per share of $5.67 in Q1 2026.
- How has Theravance Biopharma's book value per share changed year-over-year?
- Theravance Biopharma's book value per share increased by 69.7% year-over-year, from $3.34 to $5.67.
- What is the long-term trend for Theravance Biopharma's book value per share?
- Over 5 years (2020 to 2025), Theravance Biopharma's book value per share has grown at a 3.4% compound annual growth rate (CAGR), from -$4.87 to $5.76.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Theravance Biopharma's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude